Fair Value Measurements (Reconciliation For Fair Value Measurements Using Significant Unobservable Inputs) (Details) - USD ($) $ in Thousands		12 Months Ended
		Jun. 30, 2018	Jun. 30, 2017
Fair Value Measurements [Abstract]
Balance at the beginning of the period		$ (1,580)	$ (10,450)
Acquisition date fair value of contingent consideration			(1,580)
Changes in fair value included in operating income	[1]	(411)	(10,076)
Payments		486	20,142
Foreign currency translation adjustments			384
Balance at the end of the period		$ (1,505)	$ (1,580)

[1] During the year ended June 30, 2017 we recognized a charge of $10.1 million representing additional contingent consideration associated with the acquisition of Curative Medical Technology Inc., following the achievement of performance milestones under the purchase agreement which exceeded our earlier expectations.